Advertisement

Topics

Amarin Corporation PLC (AMRN) Earns Buy Rating from HC Wainwright

08:24 EDT 3 Jul 2017 | Topix

HC Wainwright currently has a $10.00 price objective on the biopharmaceutical company's stock. Several other brokerages have also issued reports on AMRN.

Original Article: Amarin Corporation PLC (AMRN) Earns Buy Rating from HC Wainwright

NEXT ARTICLE

More From BioPortfolio on "Amarin Corporation PLC (AMRN) Earns Buy Rating from HC Wainwright"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Biopharmaceuticals
Biopharmaceuticals are medical drugs produced using biotechnology. They include proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) and living microorganisms like virus and bacteria where the virulance of viruses and b...